CHIEF EXECUTIVE OFFICER’S AGREEMENTChief Executive Officer’s Agreement • April 21st, 2006 • XTL Biopharmaceuticals LTD • Pharmaceutical preparations • New York
Contract Type FiledApril 21st, 2006 Company Industry JurisdictionThis Agreement, is made and entered into this the 3rd day of January 2006, by and between XTL Biopharmaceuticals, Ltd. ("XTL" or the "Company"), an Israeli-domiciled corporation having an address at Kiryat Weizman Science Park, 3 Hasapir Street, Building 3, P.O. Box 370, Rehovat 76100, Israel and Ron Bentsur, an individual residing at 212 Highwood Avenue, Tenafly, NJ 07670, U.S.A.("Bentsur").